BR112012029913A8 - levoisovalerilespiramicina i, ii ou iii, preparações, métodos de preparação e usos dos mesmos - Google Patents
levoisovalerilespiramicina i, ii ou iii, preparações, métodos de preparação e usos dos mesmosInfo
- Publication number
- BR112012029913A8 BR112012029913A8 BR112012029913A BR112012029913A BR112012029913A8 BR 112012029913 A8 BR112012029913 A8 BR 112012029913A8 BR 112012029913 A BR112012029913 A BR 112012029913A BR 112012029913 A BR112012029913 A BR 112012029913A BR 112012029913 A8 BR112012029913 A8 BR 112012029913A8
- Authority
- BR
- Brazil
- Prior art keywords
- iii
- preparations
- preparation
- methods
- levoisovalerylspiramycin
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 3
- 239000007924 injection Substances 0.000 abstract 3
- 238000002347 injection Methods 0.000 abstract 3
- 239000000843 powder Substances 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
levoisovalespiramicina i, ii ou iii, preparações, métodos de preparação e usos dos mesmos. a presente invenção refere-se a levoisovalerilspiramicina i, ii ou iii, preparações, os métodos de preparação e ou uso dos mesmos. as preparações compreendem levoisovalerilspiramicina i, ii, ou iii e veículo farmaceuticamente aceitável e/ ou adjuvante, em que a pureza de levoisovalerilspiramicina i, ii ou iii é superior a 90% em peso. o composto levoisovalerilspiramicina i, ii ou iii tem uma boa atividade anti-bacteriana, e as preparações incluem solução para injeção, pó para injeção ou pó liofilizado para injeção.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010182108.9 | 2010-05-25 | ||
| CN201010182108 | 2010-05-25 | ||
| CN201010182111 | 2010-05-25 | ||
| CN201010182109.3 | 2010-05-25 | ||
| CN201010182109 | 2010-05-25 | ||
| CN201010182111.0 | 2010-05-25 | ||
| PCT/CN2011/074644 WO2011147313A1 (zh) | 2010-05-25 | 2011-05-25 | 左旋异戊酰螺旋霉素i、ii或iii，及其制剂、制备方法及应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112012029913A2 BR112012029913A2 (pt) | 2017-11-28 |
| BR112012029913A8 true BR112012029913A8 (pt) | 2018-01-09 |
| BR112012029913B1 BR112012029913B1 (pt) | 2021-02-02 |
Family
ID=45003321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012029913-1A BR112012029913B1 (pt) | 2010-05-25 | 2011-05-25 | levoisovalerilspiramicina i, ii, iii e preparações, métodos de preparação e uso dos mesmos |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8778896B2 (pt) |
| EP (3) | EP2578595B1 (pt) |
| JP (1) | JP5945868B2 (pt) |
| KR (2) | KR20130041829A (pt) |
| BR (1) | BR112012029913B1 (pt) |
| CA (3) | CA2800021C (pt) |
| DK (3) | DK3210991T3 (pt) |
| ES (3) | ES2754614T3 (pt) |
| MX (1) | MX340626B (pt) |
| MY (1) | MY164231A (pt) |
| PL (3) | PL2578595T3 (pt) |
| PT (1) | PT3210990T (pt) |
| RU (3) | RU2647236C1 (pt) |
| WO (1) | WO2011147313A1 (pt) |
| ZA (3) | ZA201209738B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2633737T3 (es) * | 2010-05-25 | 2017-09-25 | Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | Levocarrimicina, composiciones farmacéuticas, procedimientos de preparación y utilizaciones de la misma |
| CN105497053B (zh) * | 2015-12-31 | 2018-02-13 | 沈阳福洋医药科技有限公司 | 可利霉素在抗结核分枝杆菌感染中的应用 |
| DK3639829T3 (da) * | 2017-07-04 | 2022-05-16 | Shenyang Fuyang Pharmaceutical Tech Co Ltd | Anvendelse af isovalerylspiramycin i eller iii ved fremstilling af lægemiddel til behandling og/eller forebyggelse af tumor samt lægemiddel |
| WO2019141254A1 (zh) * | 2018-01-19 | 2019-07-25 | 沈阳福洋医药科技有限公司 | 一种mTOR抑制剂、药物组合物及其应用 |
| CA3088823A1 (en) | 2018-01-19 | 2019-07-25 | Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | Use of carrimycin or active ingredients thereof |
| CN110384710B (zh) * | 2018-04-17 | 2023-01-10 | 沈阳福洋医药科技有限公司 | 一种用于预防和/或治疗疼痛的药物、组合产品及其应用 |
| JP2021533144A (ja) * | 2018-04-17 | 2021-12-02 | 上海同聯製薬有限公司Shanghai Tonglian Pharmaceutical Co., Ltd. | 疼痛及び／又は発熱を予防及び／又は治療するための薬物、組成製品及びその応用 |
| US20220211735A1 (en) * | 2019-05-16 | 2022-07-07 | Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | Medicament and combination product used for preventing, alleviating and/or treating fibrosis, and use thereof |
| CN112239483B (zh) * | 2019-07-18 | 2023-10-27 | 沈阳福洋医药科技有限公司 | 一种化合物及药物组合物 |
| US11351185B2 (en) | 2020-03-11 | 2022-06-07 | Asclea Corporation | Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5334788A (en) * | 1976-09-11 | 1978-03-31 | Sanraku Inc | Antibiotics spiramycin derivatives |
| CN1058295C (zh) | 1997-06-03 | 2000-11-08 | 中国医学科学院医药生物技术研究所 | 一种利用基因工程技术制造生技霉素的方法 |
| CN1169947C (zh) * | 2002-11-19 | 2004-10-06 | 中国医学科学院医药生物技术研究所 | 必特螺旋霉素的基因工程菌株螺旋霉素链霉菌wsj-195 |
| CN1237976C (zh) * | 2003-12-23 | 2006-01-25 | 沈阳同联集团有限公司 | 必特螺旋霉素及其在抗感染性疾病中的应用 |
| WO2006018698A2 (en) * | 2004-08-12 | 2006-02-23 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| CN101054553A (zh) * | 2007-04-09 | 2007-10-17 | 中国医学科学院医药生物技术研究所 | 异戊酰螺旋霉素i基因工程菌株的构建 |
| CN101649325B (zh) * | 2009-07-03 | 2011-09-07 | 中国医学科学院医药生物技术研究所 | 一种提高基因工程异戊酰螺旋霉素主组分含量的基因串连技术 |
| CN101773510B (zh) * | 2010-03-09 | 2013-06-05 | 沈阳同联集团有限公司 | 异戊酰螺旋霉素iii的分离制备 |
| CN101785778A (zh) | 2010-03-09 | 2010-07-28 | 沈阳同联集团有限公司 | 异戊酰螺旋霉素i的分离制备及其应用 |
| CN101785779B (zh) * | 2010-03-09 | 2014-03-05 | 沈阳同联集团有限公司 | 异戊酰螺旋霉素ii的分离制备 |
| ES2633737T3 (es) * | 2010-05-25 | 2017-09-25 | Shenyang Fuyang Pharmaceutical Technology Co., Ltd. | Levocarrimicina, composiciones farmacéuticas, procedimientos de preparación y utilizaciones de la misma |
-
2011
- 2011-05-25 RU RU2016123979A patent/RU2647236C1/ru active IP Right Revival
- 2011-05-25 MX MX2012013470A patent/MX340626B/es active IP Right Grant
- 2011-05-25 ES ES17166118T patent/ES2754614T3/es active Active
- 2011-05-25 EP EP11786085.8A patent/EP2578595B1/en active Active
- 2011-05-25 CA CA2800021A patent/CA2800021C/en active Active
- 2011-05-25 JP JP2013511523A patent/JP5945868B2/ja active Active
- 2011-05-25 US US13/699,459 patent/US8778896B2/en active Active
- 2011-05-25 ES ES11786085.8T patent/ES2633723T3/es active Active
- 2011-05-25 DK DK17166118T patent/DK3210991T3/da active
- 2011-05-25 CA CA2915236A patent/CA2915236C/en active Active
- 2011-05-25 WO PCT/CN2011/074644 patent/WO2011147313A1/zh active Application Filing
- 2011-05-25 KR KR1020127033721A patent/KR20130041829A/ko active Application Filing
- 2011-05-25 PL PL11786085T patent/PL2578595T3/pl unknown
- 2011-05-25 PT PT171661176T patent/PT3210990T/pt unknown
- 2011-05-25 KR KR1020167002374A patent/KR101706518B1/ko active IP Right Grant
- 2011-05-25 EP EP17166117.6A patent/EP3210990B1/en active Active
- 2011-05-25 RU RU2012156420/04A patent/RU2593498C2/ru active IP Right Revival
- 2011-05-25 BR BR112012029913-1A patent/BR112012029913B1/pt not_active IP Right Cessation
- 2011-05-25 ES ES17166117T patent/ES2781425T3/es active Active
- 2011-05-25 PL PL17166118T patent/PL3210991T3/pl unknown
- 2011-05-25 PL PL17166117T patent/PL3210990T3/pl unknown
- 2011-05-25 DK DK11786085.8T patent/DK2578595T3/en active
- 2011-05-25 RU RU2016123980A patent/RU2647237C1/ru active IP Right Revival
- 2011-05-25 EP EP17166118.4A patent/EP3210991B1/en active Active
- 2011-05-25 CA CA2915222A patent/CA2915222C/en active Active
- 2011-05-25 MY MYPI2012700969A patent/MY164231A/en unknown
- 2011-05-25 DK DK17166117.6T patent/DK3210990T3/da active
-
2012
- 2012-12-21 ZA ZA2012/09738A patent/ZA201209738B/en unknown
-
2014
- 2014-08-29 ZA ZA2014/06382A patent/ZA201406382B/en unknown
- 2014-08-29 ZA ZA2014/06381A patent/ZA201406381B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012029913A2 (pt) | levoisovalespiramicina i, ii ou iii, preparações, métodos de preparação e usos dos mesmos | |
| BR112014007310A2 (pt) | 3-pirimidin-4-il-oxazolidin-2-onas como inibidores de idh mutante | |
| DOP2015000240A (es) | 3- pirimidin- 4- il- oxazolidin- 2- onas como inhibidores de idh mutante | |
| BR112014032809A8 (pt) | urolitinas, usos de uma quantidade eficaz de uma urolitina ou um sal farmaceuticamente aceitável da mesma e composição compreendendo as mesmas | |
| BR112013031268A2 (pt) | "polipeptídeos análogos de pramlintida, uso dos mesmos, composição farmacêutica compreendendo os referidos polipeptídeos e método de preparação da referida composição". | |
| MY156188A (en) | Long - acting formulations of insulins | |
| DOP2012000310A (es) | Morfolinopirimidinas y su uso en terapia | |
| BR112012026951A2 (pt) | Compostos de amino-piridazinas úteis na modulação da contratilidade do músculo esquelético, composições farmacêuticas e uso dos compostos | |
| BR112016010080A8 (pt) | compostos de pirazolopirimidina, composição farmacêutica e seu uso | |
| MX2015008628A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| BRPI0910388A2 (pt) | agentes terapêutico antivirais. | |
| DOP2016000047A (es) | Compuestos y composiciones como inhibidores de la mek | |
| IN2014CN00562A (pt) | ||
| BR112016011755A2 (pt) | derivado de ureia ou sal farmacologicamente aceitável do mesmo | |
| BR112012021364A2 (pt) | "compostos cicloalquila contendo tienopirimidinas e composições farmacêuticas". | |
| CA2920410C (en) | Thienopiperidine derivative and use thereof | |
| BR112012024712A2 (pt) | antagonistas do receptor vaniloide trpv1 com uma porção bicíclica | |
| BR112015020823A8 (pt) | 1-hidróxi-benzooxaboróis como agentes antiparasíticos, seus usos, e formulação". | |
| BR112015004523A2 (pt) | compostos de tetraciclina | |
| WO2014101295A3 (zh) | 一种詹纳斯激酶（jaks）抑制活性的异恶唑衍生物 | |
| WO2011123536A8 (en) | Polycyclic tetracycline compounds | |
| BR112014018795A2 (pt) | derivados de 1h-pirrolo[2,3-b]piridina e seu uso como inibidores de cinase | |
| AU2015275248B2 (en) | Legumain activated doxorubicin derivative as well as preparation method and application thereof | |
| BR112013024824A2 (pt) | ésteres isopentílicos para uso em composições cosméticas, dermatológicas ou farmacêuticas | |
| BR112015026967A8 (pt) | fenoxietil di-hidro-1h-isoquinolina, seus usos, e composição farmacêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: SHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/05/2011, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 13A ANUIDADE. |